Table 2.

ADI fold changes

	10-1 nM		1 nM-100 pM		100-10 pM		10-1 pM		1-0.1 pM
	Fold	SE	Fold	SE	Fold	SE	Fold	SE	Fold	SE
Prokaryotic targets only
LysX-5_at	1.55	0.18	1.65	0.17	3.84	0.68	9.53	1.99	10.22	3.16
LysX-M_at	1.14	0.22	1.45	0.22	4.06	0.73	8.73	2.31	10.18	2.83
LysX-3_at	1.38	0.23	1.25	0.13	2.74	0.43	7.97	1.83	9.82	2.14
PheX-5_at	1.44	0.24	1.43	0.15	2.74	0.24	6.90	0.94	10.23	1.96
PheX-M_at	1.29	0.27	1.38	0.18	2.46	0.24	7.66	0.88	9.69	1.65
PheX-3_at	1.22	0.34	1.15	0.21	2.24	0.33	7.18	1.21	9.03	1.57
DapX-5_at	1.53	0.19	1.76	0.25	4.30	0.87	8.65	1.99	8.97	1.89
DapX-M_at	1.35	0.24	1.62	0.17	3.84	0.66	8.50	2.14	10.22	2.33
DapX-3_at	1.14	0.20	1.76	0.23	4.19	0.75	8.85	1.93	10.18	2.60
ThrX-5_at	1.36	0.39	1.56	0.28	3.72	0.66	8.38	1.82	10.52	2.34
ThrX-M_at	1.33	0.23	1.56	0.20	4.06	0.75	9.04	2.05	9.96	2.92
ThrX-3_at	0.99	0.40	1.12	0.29	2.94	0.60	8.25	2.31	10.10	2.83
Fixed eukaryotic background
LysX-5_at	1.45	0.22	2.76	0.44	6.48	1.25	9.58	1.91	8.21	2.20
LysX-M_at	0.94	0.16	2.19	0.43	7.15	1.72	6.99	1.97	3.39	0.82
LysX-3_at	1.10	0.14	1.53	0.22	5.37	0.96	6.71	1.20	4.83	0.79
PheX-5_at	1.10	0.11	1.93	0.25	4.55	0.32	9.28	1.26	29.65	6.72
PheX-M_at	1.05	0.17	1.49	0.21	4.63	0.65	9.75	1.20	34.84	20.84
PheX-3_at	0.98	0.15	1.59	0.27	6.12	0.88	9.75	1.46	22.89	4.01
DapX-5_at	1.25	0.15	2.88	0.49	5.87	1.28	9.59	2.59	6.25	2.55
DapX-M_at	1.08	0.15	2.57	0.45	6.01	1.33	8.00	1.41	2.28	0.18
DapX-3_at	1.12	0.11	2.63	0.46	9.26	1.32	8.25	1.99	175.29	16.17
ThrX-5_at	1.11	0.17	2.09	0.37	6.14	1.34	7.90	1.57	7.37	1.26
ThrX-M_at	1.12	0.14	2.19	0.37	6.35	1.40	9.98	1.86	24.77	24.52
ThrX-3_at	0.63	0.10	1.75	0.33	5.31	0.73	9.62	2.01	11.32	1.11

The table shows ADI fold changes between consecutive tenfold dilutions (excluding negative ADIs) and standard errors in the absence (upper) and presence (lower) of 0.5 g/l eukaryotic background.